Sevoflurane and Propofol Anesthesia in Dogs with Chronic Renal Failure: Renal Functions Evaluation
World Small Animal Veterinary Association World Congress Proceedings, 2003
M.B. Carvalho; E.B. Calado; A.P. Souza; C.A.A. Valadão
Faculdade de Ciências Agrárias e Veterinárias-UNESP-Campus de Jaboticabal Via de Acesso Prof. Paulo D. Castellane, Jaboticabal, S.P., Brazil


This study evaluated the effects of sevoflurane and propofol anesthesia on renal function of dogs with naturally acquired chronic renal failure.

Materials & Methods

The anesthetic procedures included: three hours using sevoflurane (1.5CAM) in O2 flow of 30mL/kg/min, in a semiclosed-circuit, after induction with propofol at 10mg/kg, in bolus (P-S group), or after induction with sevoflurane (S-S group), and for the P group it was used only propofol in the same dose employed for induction. Evaluations were performed in six sessions and included creatinine clearance, serum creatinine and ureia, protein and glucose urinary excretion. The renal function evaluations were performed 30 minutes before anesthesia, two times during anesthesia, and one, two and five days after.


All anesthetic procedures were well succeeded and animals recovered uneventfully. No renal toxicity were observed in any of the anesthetic protocols. However, during the transanesthetic period it was observed decrease in the glomerular filtration rate and mild impairment of the tubular function, only in the group receiving sevoflurane after induction with propofol.


Although no renal toxicity were noticed, anesthesia with sevoflurane after induction with propofol must be considered with caution for dogs with renal failure.

This work was supported by FAPESP-Brazil.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

M. B. Carvalho
Faculdade de Ciências Agrárias e Veterinárias
UNESP - Campus de Jaboticabal
Via de Acesso Prof. Paulo D. Castellane
Jaboticabal, S.P., Brazil

MAIN : Urology : Sevoflurane and Propofol
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357